Currently set to Index
Currently set to Follow
Emperra ESYSTA

EMPERRA

The ESYSTA ecosystem
fighting the diabetes pandemic with a telemedicine solution

 

➔  VIEW CAMPAIGN

 

Other projects open for investment

Munevo

Smartglasses helping people with disabilities to achieve independent mobility

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Lipozyt Marker

Diagnostic Tests for the Personalized Treatment of Type 2 Diabetes

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Investment opportunities

Get notified when new campaigns are launched

Upcoming campaigns

Alma Bio Therapeutics

Targeting the cause of Autoimmune Disease – restoring immune balance without suppressing the system itself

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Mowoot

Solving intestinal transit disorders purely physical, non-drug, non-invasive

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Successfully funded

Surge-on Medical

Venture Category: MedTech
Business Phase: Sales Expansion
Professional Investors: 1 VC, 2 Family Offices

Target
€5,000,000
Investors
118
Equity
12.74%

Invest in Health

Successfully funded on our sister platform aescuvest.de

Get notified

of new campaigns and news.
We do not sell or share your data to third parties. View our Privacy notice